Article by Kingston Whig Standard
Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (the “Company” or “Organigram”), a leading licensed producer of cannabis, is pleased to announce that as of May 19th, 2020, the Company has extended its medical cannabis offering to include products from its cannabis 2.0 adult-use recreational portfolio.
Products now available to medical cannabis consumers include ready-to-use Edison Cannabis Company (Edison) vape pens powered by Feather; Edison-branded pods specifically for PAX Era vaporizers; and Edison Bytes chocolates in dark and milk chocolate, in both one and two pack formats.
“Organigram has a deep and long-standing commitment to our medical cannabis consumers,” says Greg Engel, CEO, Organigram. “As more and more patients turn their attention to new forms of cannabis, we are proud to offer them access to an innovative and growing product portfolio.”
Earlier this year, Organigram announced its first shipments of Edison vape pens, pods and cannabis-infused chocolate to retailers across Canada. This follows the Company’s $15 million investment in a high-speed, high-capacity, fully automated chocolate manufacturing line.
“We are continuously innovating, responding to the feedback from customers and building brands that we believe reflect their evolving needs and preferences. Initial feedback from our medical consumers has been very positive and we look forward to continuing to share new products with patients across the country,” says Engel.